Seeking Efficiencies, Novo Nordisk To Squeeze Costs, Boost Growth Drivers
Executive Summary
Novo Nordisk aims to offset US pricing pressures with increased cost management, freeing investment for key growth drivers like Ozempic and oral Semaglutide.